CARE Ratings Limited has informed the Exchange regarding a press release dated May 12, 2025, titled "Press Release ".
CARERATING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings reported its highest-ever standalone and consolidated income from operations for FY25, with standalone revenue rising 19% YoY to Rs. 336.7 crore and consolidated revenue growing 21% to Rs. 402.3 crore. Standalone PAT increased 24% to Rs. 147.9 crore, while consolidated PAT jumped 37% to Rs. 140 crore, with consolidated EBITDA margin expanding sharply from 34% to 39%, driven by stronger subsidiary performance. Q4 FY25 was particularly strong, with consolidated PAT up 77% YoY to Rs. 43.4 crore and EBITDA up 63%. The Ratings business grew 21% to Rs. 360.1 crore while the Non-Ratings business surged 27% to Rs. 42.2 crore. The Board recommended a final dividend of Rs. 11 per share, taking the total FY25 dividend to Rs. 18 per share on a Rs. 10 face value.
Strong all-round results with high-teens to mid-30s growth across revenue, EBITDA, and PAT, plus meaningful margin expansion and a healthy dividend, are likely to be viewed positively by shareholders and could support the stock price.